Vanguard Personalized Indexing Management
RVMD icon

Vanguard Personalized Indexing Management’s Revolution Medicines RVMD Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.31M Buy
17,697
+3,200
+22% +$467K 0.03% 468
2026
Q1 		$1.41M Buy
14,497
+1,128
+8% +$114K 0.01% 761
2025
Q4 		$1.06M Buy
13,369
+1,061
+9% +$69.6K 0.01% 887
2025
Q3 		$575K Sell
12,308
-382
-3% -$15K 0.01% 1184
2025
Q2 		$467K Buy
12,690
+6,297
+98% +$242K 0.01% 1231
2025
Q1 		$226K Sell
6,393
-153
-2% -$6.21K ﹤0.01% 1463
2024
Q4 		$286K Sell
6,546
-248
-4% -$12.5K ﹤0.01% 1353
2024
Q3 		$308K Buy
+6,794
New +$296K 0.01% 1333

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Personalized Indexing Management's RVMD Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Revolution Medicines (RVMD) stake by 22% in Q2 2026, buying an estimated $467K and bringing the position to 17,697 shares worth $3.31M. The position accounts for 0.03% of the portfolio, ranked #468.

Vanguard Personalized Indexing Management first reported a position in RVMD in Q3 2024 and has held it in 8 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Vanguard Personalized Indexing Management held 17,697 shares of Revolution Medicines worth $3.31M as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 3,200 Revolution Medicines shares in Q2 2026, an estimated $467K.
  • Revolution Medicines made up 0.03% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #468 holding.
  • Vanguard Personalized Indexing Management first reported a position in Revolution Medicines in Q3 2024 and has held it in 8 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.